Monday, June 11, 2007

Myriad Genetics (MYGN) Presents Mathematical Comparison of Disease Modification Trial Designs at Alzheimer's Conference


Current Flurizan™ Phase 3 Study Design May Demonstrate Disease Modification

Read the entire release at The Alzheimer's Reading Room





Thursday, June 07, 2007

Will Friday’s Close Spell Doomsday for Stocks?



On Friday we could see a rare occurrence in stocks, a fourth day down right after a new high in a long term move. Why is this important?



Will Friday’s Close Spell Doomsday for Stocks?